Medicare Compliance & Reimbursement

Industry Notes:

CMS Waives 5 Additional Lab Tests

Plus: CMS may expand diagnostic testing coverage for cancer patients' PET scans. You'll have five lab codes that you'll be able to report as "CLIA-waived," thanks to a Dec. 19 CMS transmittal on the matter. According to Transmittal 1652, CMS will now consider these five tests CLIA-waived effective last week (Jan. 1). You'll have to append modifier QW (CLIA-waived test) to these codes, which include the following: • 83036-QW -- DCA Vantage analyzer • 81003-QW -- OneStepPlus urine analyzer • 82274-QW/G0328QW -- Fecal occult blood tests • 80101-QW -- Home check multiple drug cup test • 83986-QW -- VA-SENSE kit. To read the full list of CLIA-waived tests, visit the CMS Web site at www.cms.hhs.gov/transmittals/downloads/R1652CP.pdf.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Medicare Compliance & Reimbursement

View All